Which medications interact with isotretinoin (Accutane)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Isotretinoin (Accutane) Drug Interactions

Isotretinoin has several clinically significant drug interactions that require careful attention, most notably with tetracyclines (which must be avoided), vitamin A supplements, and certain contraceptives.

Critical Interactions to Avoid

Tetracycline Antibiotics

  • Tetracyclines must be avoided during isotretinoin therapy due to the risk of pseudotumor cerebri (benign intracranial hypertension) 1.
  • This includes tetracycline, doxycycline, and minocycline 2.
  • The combination of these medications can cause increased intracranial pressure, which is a serious adverse effect 3.

Vitamin A Supplementation

  • Concomitant vitamin A supplementation must be avoided to prevent additive toxic effects and hypervitaminosis A 1.
  • Patients should not exceed the recommended daily allowance of vitamin A (2400-3000 IU daily, equivalent to 0.8-1 mg daily) 2.
  • Since isotretinoin is a vitamin A derivative, combining it with additional vitamin A creates cumulative toxicity 3.

Contraceptive Interactions

Progestin-Only "Mini-Pills"

  • Micro-dosed progestin preparations (mini-pills without estrogen) may be inadequate contraception during isotretinoin therapy 1.
  • Isotretinoin decreases the anti-ovulatory effect of progestin-only pills but does not affect combined oral contraceptives 2.
  • Given isotretinoin's severe teratogenicity, two forms of effective contraception are mandatory, with at least one being a primary method 1.

Combined Oral Contraceptives

  • Combined oral contraceptives (containing both estrogen and progestin) are not significantly affected by isotretinoin 1.
  • A study showed isotretinoin at 1 mg/kg/day did not induce clinically relevant changes in ethinyl estradiol or norethindrone pharmacokinetics 1, 4.
  • However, pregnancies have been reported in patients using only single contraceptive methods, reinforcing the need for dual contraception 1.

St. John's Wort

  • Patients should avoid St. John's Wort as it may reduce hormonal contraceptive effectiveness through breakthrough bleeding 1.
  • Pregnancies have been reported in users of combined hormonal contraceptives who also used St. John's Wort 1.

Medications Requiring Caution

Phenytoin

  • Isotretinoin may reduce protein binding of phenytoin, though clinical significance is uncertain 3, 2, 3.
  • Both phenytoin and isotretinoin can affect bone health (phenytoin causes osteomalacia), so caution is warranted when using together 1.
  • Formal studies show isotretinoin does not alter phenytoin pharmacokinetics via CYP2C9 1.

Antidiabetic Agents (Glyburide/Glibenclamide)

  • Isotretinoin may potentiate the glucose-lowering effect of glyburide, increasing hypoglycemia risk 3, 5.
  • Use with caution or avoid in patients taking this medication 3.
  • More frequent blood glucose monitoring is recommended in diabetic patients on isotretinoin 2.

Systemic Corticosteroids

  • Both systemic corticosteroids and isotretinoin can affect bone health (corticosteroids cause osteoporosis) 1.
  • Exercise caution when combining these medications, though no formal interaction studies exist 1.
  • Corticosteroids also increase hyperlipidemia risk, which is already elevated with isotretinoin 2.

Methotrexate

  • Combined use requires caution due to additive hepatotoxicity risk 3, 2, 3.
  • Sporadic episodes of toxic hepatitis have been reported with the combination 2, 5.
  • Both medications can cause liver function test abnormalities 3.

Cyclosporine

  • Drugs interfering with the cytochrome P450 pathway, such as cyclosporine, may affect isotretinoin metabolism 3.
  • Clinical significance requires monitoring when used together 3.

Important Clinical Considerations

Alcohol

  • Patients must abstain from alcohol during isotretinoin therapy because concurrent ingestion can convert acitretin to etretinate, which has a much longer half-life 3.
  • This is particularly critical for women of childbearing potential due to prolonged teratogenic risk 2.

Blood Donation

  • Patients must not donate blood during therapy and for one month following discontinuation 1.
  • This prevents potential exposure of pregnant recipients to isotretinoin 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.